KTX-1001

DB18171InvestigationalSmall molecule

KTX-1001: Overview.

Mechanism: Pharmacologically active on Histone-lysine N-methyltransferase NSD2
Curator reviewed
Also known as: (S)-1-((R)-3-amino-1-(4-((6-amino-9H-purin-9-yl)methyl)-6-(2,5-difluoro-4-methoxyphenyl)pyridin-3-yl)piperidin-3-yl)-2,2-difluoroethan-1-ol
Code names: KTX-1001

Resolves to

Compound

Targets

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with KTX-1001, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.